TRAVEL-Dx – Rapid Testing for Enhanced Mobility in the Pandemic
Rapid-Testing on site, are first line of defense against spreading of COVID-19. However, PCR-based testing is cumbersome and not fast enough. Together with University of Potsdam, IZI-BB developes isothermal nucleic acid amplification for use without a lab. This will be the basis for rapid nucleic acid testing and may easily be performed on site. The project is part of IMDB-action, the Diagnostik-BB response to the challenges of COVID-19 and funded by the German Ministry of Education and Research.